Mesenchymal stem cells protective effect in adriamycin model of nephropathy

Alberto Magnasco, Mirko Corselli, Roberta Bertelli, Adalberto Ibatici, Monica Peresi, Gabriele Gaggero, Valentina Cappiello, Barbara Chiavarina, Girolamo Mattioli, Rosanna Gusmano, Jean Louis Ravetti, Francesco Frassoni, Gian Marco Ghiggeri

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) may be of value in regeneration of renal tissue after damage; however, lack of biological knowledge and variability of results in animal models limit their utilization. We studied the effects of MSCs on podocytes in vitro and in vivo utilizing adriamycin (ADR) as a model of renal toxicity. The in vivo experimental approach was carried out in male Sprague-Dawley rats (overall 60 animals) treated with different ADR schemes to induce acute and chronic nephrosis. MSCs were given a) concomitantly to ADR in tail vein or b) in aorta and c) in tail vein 60 days after ADR. Homing was assessed with PKH26-MSCs. MSCs rescued podocytes from apoptosis induced by ADR in vitro. The maximal effect (80% rescue) was obtained with MSCs/podocytes coculture ratio of 1:1 for 72 h. All rats treated with ADR developed nephrosis. MSCs did not modify the clinical parameters (i.e., proteinuria, serum creatinine, lipids) but protected the kidney from severe glomerulosclerosis when given concomitantly to ADR. Rats given MSCs 60 days after ADR developed the same severe renal damage. Only a few MSCs were found in renal tubule-interstitial areas 1-24 h after injection and no MSCs were detected in glomeruli. MSCs reduced apoptosis of podocytes treated with ADR in vitro. Early and repeated MSCs infusion blunted glomerular damage in chronic ADR-induced nephropathy. MSCs did not modify proteinuria and progression to renal failure, which implies lack of regenerative potential in this model.

Original languageEnglish
Pages (from-to)1157-1167
Number of pages11
JournalCell Transplantation
Volume17
Issue number10-11
Publication statusPublished - 2008

Fingerprint

Stem cells
Mesenchymal Stromal Cells
Doxorubicin
Podocytes
Kidney
Nephrosis
Rats
Cell death
Proteinuria
Tail
Veins
Animals
Apoptosis
Coculture Techniques
Lipids
Renal Insufficiency
Sprague Dawley Rats
Toxicity
Aorta
Regeneration

Keywords

  • Adriamycin
  • Kidney
  • Mesenchymal stem cells (MSCs)
  • Nephrotic syndrome
  • Podocytes
  • Regeneration

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

Mesenchymal stem cells protective effect in adriamycin model of nephropathy. / Magnasco, Alberto; Corselli, Mirko; Bertelli, Roberta; Ibatici, Adalberto; Peresi, Monica; Gaggero, Gabriele; Cappiello, Valentina; Chiavarina, Barbara; Mattioli, Girolamo; Gusmano, Rosanna; Ravetti, Jean Louis; Frassoni, Francesco; Ghiggeri, Gian Marco.

In: Cell Transplantation, Vol. 17, No. 10-11, 2008, p. 1157-1167.

Research output: Contribution to journalArticle

Magnasco, A, Corselli, M, Bertelli, R, Ibatici, A, Peresi, M, Gaggero, G, Cappiello, V, Chiavarina, B, Mattioli, G, Gusmano, R, Ravetti, JL, Frassoni, F & Ghiggeri, GM 2008, 'Mesenchymal stem cells protective effect in adriamycin model of nephropathy', Cell Transplantation, vol. 17, no. 10-11, pp. 1157-1167.
Magnasco A, Corselli M, Bertelli R, Ibatici A, Peresi M, Gaggero G et al. Mesenchymal stem cells protective effect in adriamycin model of nephropathy. Cell Transplantation. 2008;17(10-11):1157-1167.
Magnasco, Alberto ; Corselli, Mirko ; Bertelli, Roberta ; Ibatici, Adalberto ; Peresi, Monica ; Gaggero, Gabriele ; Cappiello, Valentina ; Chiavarina, Barbara ; Mattioli, Girolamo ; Gusmano, Rosanna ; Ravetti, Jean Louis ; Frassoni, Francesco ; Ghiggeri, Gian Marco. / Mesenchymal stem cells protective effect in adriamycin model of nephropathy. In: Cell Transplantation. 2008 ; Vol. 17, No. 10-11. pp. 1157-1167.
@article{db42501755364d5a95311d078229d705,
title = "Mesenchymal stem cells protective effect in adriamycin model of nephropathy",
abstract = "Mesenchymal stem cells (MSCs) may be of value in regeneration of renal tissue after damage; however, lack of biological knowledge and variability of results in animal models limit their utilization. We studied the effects of MSCs on podocytes in vitro and in vivo utilizing adriamycin (ADR) as a model of renal toxicity. The in vivo experimental approach was carried out in male Sprague-Dawley rats (overall 60 animals) treated with different ADR schemes to induce acute and chronic nephrosis. MSCs were given a) concomitantly to ADR in tail vein or b) in aorta and c) in tail vein 60 days after ADR. Homing was assessed with PKH26-MSCs. MSCs rescued podocytes from apoptosis induced by ADR in vitro. The maximal effect (80{\%} rescue) was obtained with MSCs/podocytes coculture ratio of 1:1 for 72 h. All rats treated with ADR developed nephrosis. MSCs did not modify the clinical parameters (i.e., proteinuria, serum creatinine, lipids) but protected the kidney from severe glomerulosclerosis when given concomitantly to ADR. Rats given MSCs 60 days after ADR developed the same severe renal damage. Only a few MSCs were found in renal tubule-interstitial areas 1-24 h after injection and no MSCs were detected in glomeruli. MSCs reduced apoptosis of podocytes treated with ADR in vitro. Early and repeated MSCs infusion blunted glomerular damage in chronic ADR-induced nephropathy. MSCs did not modify proteinuria and progression to renal failure, which implies lack of regenerative potential in this model.",
keywords = "Adriamycin, Kidney, Mesenchymal stem cells (MSCs), Nephrotic syndrome, Podocytes, Regeneration",
author = "Alberto Magnasco and Mirko Corselli and Roberta Bertelli and Adalberto Ibatici and Monica Peresi and Gabriele Gaggero and Valentina Cappiello and Barbara Chiavarina and Girolamo Mattioli and Rosanna Gusmano and Ravetti, {Jean Louis} and Francesco Frassoni and Ghiggeri, {Gian Marco}",
year = "2008",
language = "English",
volume = "17",
pages = "1157--1167",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "10-11",

}

TY - JOUR

T1 - Mesenchymal stem cells protective effect in adriamycin model of nephropathy

AU - Magnasco, Alberto

AU - Corselli, Mirko

AU - Bertelli, Roberta

AU - Ibatici, Adalberto

AU - Peresi, Monica

AU - Gaggero, Gabriele

AU - Cappiello, Valentina

AU - Chiavarina, Barbara

AU - Mattioli, Girolamo

AU - Gusmano, Rosanna

AU - Ravetti, Jean Louis

AU - Frassoni, Francesco

AU - Ghiggeri, Gian Marco

PY - 2008

Y1 - 2008

N2 - Mesenchymal stem cells (MSCs) may be of value in regeneration of renal tissue after damage; however, lack of biological knowledge and variability of results in animal models limit their utilization. We studied the effects of MSCs on podocytes in vitro and in vivo utilizing adriamycin (ADR) as a model of renal toxicity. The in vivo experimental approach was carried out in male Sprague-Dawley rats (overall 60 animals) treated with different ADR schemes to induce acute and chronic nephrosis. MSCs were given a) concomitantly to ADR in tail vein or b) in aorta and c) in tail vein 60 days after ADR. Homing was assessed with PKH26-MSCs. MSCs rescued podocytes from apoptosis induced by ADR in vitro. The maximal effect (80% rescue) was obtained with MSCs/podocytes coculture ratio of 1:1 for 72 h. All rats treated with ADR developed nephrosis. MSCs did not modify the clinical parameters (i.e., proteinuria, serum creatinine, lipids) but protected the kidney from severe glomerulosclerosis when given concomitantly to ADR. Rats given MSCs 60 days after ADR developed the same severe renal damage. Only a few MSCs were found in renal tubule-interstitial areas 1-24 h after injection and no MSCs were detected in glomeruli. MSCs reduced apoptosis of podocytes treated with ADR in vitro. Early and repeated MSCs infusion blunted glomerular damage in chronic ADR-induced nephropathy. MSCs did not modify proteinuria and progression to renal failure, which implies lack of regenerative potential in this model.

AB - Mesenchymal stem cells (MSCs) may be of value in regeneration of renal tissue after damage; however, lack of biological knowledge and variability of results in animal models limit their utilization. We studied the effects of MSCs on podocytes in vitro and in vivo utilizing adriamycin (ADR) as a model of renal toxicity. The in vivo experimental approach was carried out in male Sprague-Dawley rats (overall 60 animals) treated with different ADR schemes to induce acute and chronic nephrosis. MSCs were given a) concomitantly to ADR in tail vein or b) in aorta and c) in tail vein 60 days after ADR. Homing was assessed with PKH26-MSCs. MSCs rescued podocytes from apoptosis induced by ADR in vitro. The maximal effect (80% rescue) was obtained with MSCs/podocytes coculture ratio of 1:1 for 72 h. All rats treated with ADR developed nephrosis. MSCs did not modify the clinical parameters (i.e., proteinuria, serum creatinine, lipids) but protected the kidney from severe glomerulosclerosis when given concomitantly to ADR. Rats given MSCs 60 days after ADR developed the same severe renal damage. Only a few MSCs were found in renal tubule-interstitial areas 1-24 h after injection and no MSCs were detected in glomeruli. MSCs reduced apoptosis of podocytes treated with ADR in vitro. Early and repeated MSCs infusion blunted glomerular damage in chronic ADR-induced nephropathy. MSCs did not modify proteinuria and progression to renal failure, which implies lack of regenerative potential in this model.

KW - Adriamycin

KW - Kidney

KW - Mesenchymal stem cells (MSCs)

KW - Nephrotic syndrome

KW - Podocytes

KW - Regeneration

UR - http://www.scopus.com/inward/record.url?scp=60549115287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549115287&partnerID=8YFLogxK

M3 - Article

C2 - 19181210

AN - SCOPUS:60549115287

VL - 17

SP - 1157

EP - 1167

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 10-11

ER -